Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Biodentine as Pulp Medicaments in Primary Molars

Pulp Disease, Dental Clinical Trial

Official title: Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Biodentine as Pulp Medicaments in Primary Molars

Status Recruiting

Clinical Trial Summary

The aim of the present study is to evaluate Mineral Trioxide Aggregate and Biodentine in direct pulp capping, partial pulpotomy, and pulpotomy in primary molars.

Clinical Trial Description

Screening of patients will continue until the target population is achieved. Identifying and recruiting potential subjects is achieved through patient database in Pediatric Dentistry department.

A total of 150 primary molars from healthy subjects will be selected from the Pediatric Dentistry and Dental Public Health outpatient clinic, Faculty of Dentistry, Ain shams University.

Subjects will be assigned randomly into two different treatment groups as follows:

MTA Group (1):

1. Group 1(A): MTA Direct Pulp Capping. (n=25)

2. Group 1 (B): MTA Partial Pulpotomy. (n=25)

3. Group 1 (C): MTA Complete Pulpotomy. (n=25)

BiodentineTM Group (2):

1. Group 2(A): BiodentineTM Direct Pulp Capping. (n=25)

2. Group 2 (B): BiodentineTM Partial Pulpotomy. (n=25)

3. Group 2 (C): BiodentineTM Complete Pulpotomy. (n=25) ;

Related Conditions & MeSH terms

• Dental Pulp Diseases
• Pulp Disease, Dental
• Stomatognathic Diseases

• NCT number: NCT05102318
• Study type: Interventional
• Source: British University In Egypt
• Contact: Marwa Magdy, PhD
• Phone: 00201007195996
• Email: marwa.magdy@bue.edu.eg
• Status: Recruiting
• Phase: N/A
• Start date: April 1, 2020
• Completion date: September 1, 2022